Non-selective monoamine reuptake inhibitors

Protriptyline Hydrochloride

Approved 16 Sept 2008OralTablet

The FDA lists this product in 6 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: PROTRIPTYLINE HYDROCHLORIDE 5MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA078913.

Open Drugs@FDA

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Protriptyline Hydrochloride
Drug class: Non-selective monoamine reuptake inhibitors
Group: Antidepressants
Route: Oral
Dosage form: Tablet
Applicant: Hikma
Status: Discontinued
FDA approval: 16 Sept 2008
Application: ANDA078913-001
RxCUI: 203199

Guidelines

FDA 2023

Doxepin HydrochlorideCream

SafinamideTablet

LevomilnacipranCapsule, extended release

Zulressobrexanolone · Solution

Spravatoesketamine hydrochloride · Spray

Dextromethorphan Hydrobromide and Quinidine Sulfatedextromethorphan hydrobromide · Capsule

Milnacipran HydrochlorideTablet

Guaifenesin and Dextromethorphan Hydrobromidedextromethorphan hydrobromide · Tablet, extended release

Desvenlafaxine SuccinateTablet, extended release

Duloxetine HydrochlorideCapsule, delayed rel pellets

Khedezladesvenlafaxine · Tablet, extended release

Rasagiline MesylateTablet

Brisdelleparoxetine mesylate · Capsule

Fluvoxamine MaleateCapsule, extended release

DesvenlafaxineTablet, extended release

Olanzapine and Fluoxetine Hydrochloridefluoxetine hydrochloride · Capsule

Escitalopram OxalateSolution